Annals of Clinical Microbiology and Antimicrobials Open Access Imported Per-1 Producing Pseudomonas Aeruginosa, Per-1 Producing Acinetobacter Baumanii and Vim-2-producing Pseudomonas Aeruginosa Strains in Hungary

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary.

  2008cited by this paper
• Outbreak of Pseudomonas aeruginosa Infections with PER-1 Extended-Spectrum β-Lactamase in Warsaw, Poland: Further Evidence for an International Clonal Complex

  2007cited by this paper
• Intercountry transfer of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii from Romania.

  2007cited by this paper
• Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

  2006cited by this paper
• Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae strains in Hungary

  2006cited by this paper
• Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in the Calgary Health Region: Emergence of VIM-2-Producing Isolates

  2006cited by this paper
• Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamases and carrying two aminoglycoside-modifying enzymes in China.

  2006cited by this paper
• Occurrence of PER-1 Producing Clinical Isolates of Pseudomonas aeruginosa in Japan and their Susceptibility to Doripenem

  2006cited by this paper
• Molecular Epidemiology of VIM-4 Metallo-β-Lactamase-Producing Pseudomonas sp. Isolates in Hungary

  2006cited by this paper
• blaVIM-2 and blaVIM-7 Carbapenemase-Producing Pseudomonas aeruginosa Isolates Detected in a Tertiary Care Medical Center in the United States: Report from the MYSTIC Program

  2006cited by this paper
• First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt.

  2006cited by this paper
• Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea.

  2005cited by this paper
• Investigation of a nosocomial outbreak of Acinetobacter baumannii producing PER-1 extended-spectrum beta-lactamase in an intensive care unit.

  2005cited by this paper
• PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.

  2005cited by this paper
• Occurrence and regional distribution of SHV-type extended-spectrum β-lactamases in Hungary

  2005cited by this paper
• Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia.

  2005cited by this paper
• Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program.

  2005cited by this paper
• Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain.

  2005cited by this paper
• Overview of nosocomial infections caused by gram-negative bacilli.

  2005cited by this paper
• Multifocal Detection of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum β-Lactamase in Northern Italy

  2004cited by this paper
• Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.

  2004cited by this paper
• Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program.

  2003cited by this paper
• IMP-12, a New Plasmid-Encoded Metallo-β-Lactamase from a Pseudomonas putida Clinical Isolate

  2003cited by this paper
• High Prevalence of PER-1 Extended-Spectrum β-Lactamase-Producing Acinetobacter spp. in Korea

  2003cited by this paper
• Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii.

  2002cited by this paper
• Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism.

  2002cited by this paper
• Prospective Survey of β-Lactamases Produced by Ceftazidime- Resistant Pseudomonas aeruginosa Isolated in a French Hospital in 2000

  2002cited by this paper
• Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniae.

  2001cited by this paper
• Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains.

  2001cited by this paper
• Complexity and Diversity of Klebsiella pneumoniae Strains with Extended-Spectrum β-Lactamases Isolated in 1994 and 1996 at a Teaching Hospital in Durban, South Africa

  2001cited by this paper
• Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study

  1997cited by this paper
• Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa

  1995cited by this paper
• Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa

  1993cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

  1990cited by this paper

• Silver Nanoparticles Functionalized with Polymeric Substances to Reduce the Growth of Planktonic and Biofilm Opportunistic Pathogens

  2025cites this paper
• Multidrug-Resistant Acinetobacter baumannii Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions

  2023cites this paper
• Characteristics Of The Pseudomonas aeruginosa And How To Prevention From Them.

  2022cites this paper
• Insights on carbapenem-resistant Pseudomonas aeruginosa

  2021influential citation
• It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa

  2021cites this paper
• Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.

  2021cites this paper
• Travel-Related Antimicrobial Resistance: A Systematic Review

  2021cites this paper
• Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides—A Review

  2020cites this paper
• Molecular Detection of <em>Adefg</em> Efflux Pump Genes and their Contribution to Antibiotic Resistance in <em>Acinetobacter baumannii</em> Clinical Isolates

  2020cites this paper
• Molecular Detection of Adefg Efflux Pump Genes and their Contribution to Antibiotic Resistance in Acinetobacter baumannii Clinical Isolates.

  2020cites this paper
• Multidrug-resistant : mechanisms of virulence and resistance

  2020cites this paper
• Therapeutic nanostructures: novel approaches

  2019cites this paper
• Properties and Prevention: A Review ofPseudomonas aeruginosa

  2018cites this paper
• Resistance to Antibiotics and the Occurrence of Genes Responsible for the Development of Methicillin Resistance in Staphylococcus Bacteria Isolated From the Environment of Horse Riding Centers

  2018cites this paper
• Antibiotic resistance and presence of blaPER-1, blaVEB-1 and blaPSE-1 beta-lacamases among clinical isolates of Pseudomonas aeruginosa from ICU settings

  2018cites this paper
• Resistance Pattern and Detection of Metallo-beta-lactamase Genes in Clinical Isolates of Pseudomonas aeruginosa in a Central Nigeria Tertiary Hospital

  2018cites this paper
• Prevalence of resistance to colistin, tigecycline and minocycline in Acinetobacter baumannii isolated from clinical samples in 2014

  2018cites this paper
• ANTIMICROBIAL SUSCEPTIBILITY – CONTINUING CLINICAL IMPORTANCE OF ACINETOBACTER INFECTIONS AND THE ROLES OF MDR MECHANISMS INCLUDING OXA-CARBAPENEMASES Sample ES-01 (2018) was a simulated sputum culture from a 68-year old female with suspected pneumonia/sepsis. The organism Acinetobacter baumannii wa

  2018cites this paper
• Molecular characterization of plasmid-encoded blaTEM, blaSHV and blaCTX-M among extended spectrum β-lactamases [ESBLs] producing Acinetobacter baumannii

  2018cites this paper
• ESBL and MBL mediated resistance in clinical isolates of non-fermenting gram negative bacilli ( NFGNB ) in Nepal

  2017cites this paper
• Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases.

  2015cites this paper
• Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.

  2015influential citation
• Identification of a novel metallo-β-lactamase VIM-28 located within unusual arrangement of class 1 integron structure in Pseudomonas aeruginosa isolates from Egypt.

  2014cites this paper
• Dissemination of IMP-6-producing Pseudomonas aeruginosa ST244 in multiple cities in China

  2014cites this paper
• Identification of VIM-2-Producing Pseudomonas aeruginosa from Tanzania Is Associated with Sequence Types 244 and 640 and the Location of blaVIM-2 in a TniC Integron

  2014cites this paper
• Annaba, Algeria from a Hospital Intensive Care Unit in Pseudomonas aeruginosa Clinical Isolates Carrying VIM-2 Carbapenemase in Dissemination of a Class I Integron

  2013cites this paper
• Incidence, prevalence and control of multidrug resistant (MDR) carbapenemase producing Acinetobacter baumanii in Indian intensive care units

  2013cites this paper
• Identific ation of bla OXA-51-like , bla OXA-58 , bla DIM-1 , and bla VIM Carbapenemase Genes in Hospital EnterobacteriaceaeIsolates from Sierra

  2013cites this paper
• Characterization of the Extended-Spectrum beta-Lactamase Producers among Non-Fermenting Gram-Negative Bacteria Isolated from Burnt Patients

  2013cites this paper
• Estudo da Frequência Temporal e Padronização de uma PCR Multiplex para a Detecção de Oxacilinases em Isolados Clínicos de Pseudomonas aeruginosa

  2013cites this paper
• In vitro susceptibilities of 116 clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa to conventional and new antibacterial agents

  2013cites this paper
• Isolates from Sierra Leone Genes in Hospital Enterobacteriaceae blaDIM-1, and blaVIM Carbapenemase Identification of blaOXA-51-like, blaOXA-58,

  2013cites this paper
• Dissemination of a Class I Integron Carrying VIM-2 Carbapenemase in Pseudomonas aeruginosa Clinical Isolates from a Hospital Intensive Care Unit in Annaba, Algeria

  2013cites this paper
• Identification of bla OXA-51-like, bla OXA-58, bla DIM-1, and bla VIM Carbapenemase Genes in Hospital Enterobacteriaceae Isolates from Sierra Leone

  2013cites this paper
• Antibiotic resistance mechanisms in Enterobacteriaceae

  2013cites this paper
• Emergence of an Antimicrobial Resistant Pseudomonas aeruginosa from Human and Animal Clinical Samples: A zoonotic and Public Health Hazard

  2013cites this paper
• Molecular Characterization of Multidrug Resistant Hospital Isolates Using the Antimicrobial Resistance Determinant Microarray

  2013cites this paper
• Rising Antimicrobial Resistance of Pseudomonas aeruginosa Isolated fromClinical Specimens in India

  2012cites this paper
• Susceptibility, phenotypes of resistance, and extended-spectrum β-lactamases in Acinetobacter baumannii strains.

  2012cites this paper
• Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.

  2012cites this paper
• Molecular Characterization and Antimicrobial Susceptibility Study of Acinetobacter baumannii Clinical Isolates from Middle East, African andIndian Patients

  2012cites this paper
• Characterization of medically important Pseudomonas aeruginosa isolates

  2011influential citation
• Metallo-β-lactamases: a last frontier for β-lactams?

  2011cites this paper
• Misidentification of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in Tripoli, Libya

  2010cites this paper
• Isolation and characterization of an imported extremely-resistant Pseudomonas aeruginosa producing three different extended-spectrum β-lactamases and hyperproducing two multidrug-efflux pumps.

  2010cites this paper
• Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.

  2010cites this paper
• Identification of Two Multidrug-Resistant Pseudomonas aeruginosa Clonal Lineages with a Countrywide Distribution in Hungary

  2009cites this paper
• Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital.

  2009cites this paper
• Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia.

  2009cites this paper
• Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia.

  2008cites this paper